Effect of COVID-19 on diabetes in Black Asian and Minority Ethnic (BAME) patients

Impact of COVID-19 on staff and patients from the Black Asian and Minority Ethnic (BAME) community with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN15351917

Enrollment

100

Registered

2021-07-01

Start date

2021-05-31

Completion date

Unknown

Last updated

2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impact of COVID-19 (SARS-CoV-2 infection) on diabetes in the BAME population Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Patients will be identified from the researchers' database (from Business Intelligence and Occupational Health) by applying inclusion and exclusion criteria. They will be invited to participate in the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 18 years and above 2. Identifies as Black, Asian or Minority Ethnic (BAME) 3. Diagnosed COVID-19 with viral PCR nasal swab in hospital or community 4. Diagnosed type 1 or type 2 diabetes mellitus (T1DM or T2DM, according to WHO criteria) prior to or after COVID-19 diagnosis 5. Able to provide informed consent and willing to participate in the study and follow the instructions

Exclusion criteria

Exclusion criteria: 1. From any other demographic not in the BAME group 2. Not confirmed COVID-19 with viral PCR nasal swab in hospital or community 3. Not confirmed T1DM or T2DM according to WHO criteria 4. Unwilling/unable to participate or comply with the protocol

Design outcomes

Primary

Measure	Time frame
Glycated haemoglobin (HbA1c) measured using blood test pre and post COVID-19 infection within 12 months	—

Secondary

Measure	Time frame
1. Body mass index measured using BMI calculator pre and post COVID-19 infection within 12 months 2. Renal function measured using blood test pre and post COVID-19 infection within 12 months 3. Blood pressure measured using calibrated blood pressure machine pre and post COVID-19 infection within 12 months 4. Lipid profile measured using blood test pre and post COVID-19 infection within 12 months 5. Proteinuria measured using urine sample pre and post COVID-19 infection within 12 months 6. Depression, anxiety and eating disorders measured using a psychologist-developed questionnaire (Diabetes and COVID-19 Participant Questionnaire Booklet) post COVID-19 infection within 12 months	—

Measure

Time frame

1. Body mass index measured using BMI calculator pre and post COVID-19 infection within 12 months 2. Renal function measured using blood test pre and post COVID-19 infection within 12 months 3. Blood pressure measured using calibrated blood pressure machine pre and post COVID-19 infection within 12 months 4. Lipid profile measured using blood test pre and post COVID-19 infection within 12 months 5. Proteinuria measured using urine sample pre and post COVID-19 infection within 12 months 6. Depression, anxiety and eating disorders measured using a psychologist-developed questionnaire (Diabetes and COVID-19 Participant Questionnaire Booklet) post COVID-19 infection within 12 months

—

Countries

England, United Kingdom

Contacts

Public ContactRajdeep;Rajiv Heire;Singh

;

rajdeep.heire@nhs.net;rajiv.singh5@nhs.net+44 (0)7947752111;+44 (0)7402592979

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026